CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | Xie Jian President and COO | Sale | −1,269 | $53.38 | $68K | 329,701 |
| 2022-05-16 | KIM PAUL CFO and Treasurer | Sale | −325 | $53.38 | $17K | 154,443 |
| 2022-05-16 | KIM PAUL CFO and Treasurer | Sale | −866 | $53.38 | $46K | 153,577 |
| 2022-05-16 | Gao Hanlin Chief Scientific Officer | Sale | −325 | $53.38 | $17K | 855,737 |
| 2022-05-03 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −806 | $56.69 | $46K | 154,768 |
| 2022-05-03 | Xie Jian President and COO | Shares withheld for taxes | −5,904 | $56.69 | $335K | 330,970 |
| 2022-05-01 | Xie Jian President and COO | Shares withheld for taxes | −738 | $54.88 | $41K | 336,874 |
| 2022-04-30 | Gao Hanlin Chief Scientific Officer | Shares withheld for taxes | −283 | $54.88 | $16K | 856,062 |
| 2022-03-03 | KIM PAUL CFO and Treasurer | Sale | −454 | $56.31 | $26K | 155,574 |
| 2022-03-01 | BOLGER JOHN C Director | Option exercise | +625 | $3.93 | $2K | 2,625 |
| 2022-03-01 | BOLGER JOHN C Director | Sale | −625 | $61.42 | $38K | 2,000 |
| 2022-03-01 | BOLGER JOHN C Director | Option exercise | +625 | $5.81 | $4K | 2,625 |
| 2022-03-01 | BOLGER JOHN C Director | Sale | −625 | $61.40 | $38K | 2,000 |
| 2022-03-01 | BOLGER JOHN C Director | Option exercise | +625 | $15.82 | $10K | 2,625 |
| 2022-03-01 | BOLGER JOHN C Director | Sale | −625 | $61.27 | $38K | 2,000 |
| 2022-03-01 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −625 | 313 | ||
| 2022-03-01 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −625 | 1,563 | ||
| 2022-03-01 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −625 | 2,813 | ||
| 2022-03-01 | Xie Jian Chief Operating Officer | Sale | −622 | $63.30 | $39K | 337,612 |
| 2022-02-28 | Xie Jian Chief Operating Officer | Grant or award | +9,000 | 306,234 |
Page 20 of 23 · 453 trades